Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | core-binding factor, beta subunit | No references | |
Homo sapiens | vitamin D (1,25- dihydroxyvitamin D3) receptor | Starlite/ChEMBL | No references |
Mus musculus | RAR-related orphan receptor gamma | Starlite/ChEMBL | No references |
Homo sapiens | runt-related transcription factor 1 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | Get druggable targets OG5_133916 | All targets in OG5_133916 |
Onchocerca volvulus | Get druggable targets OG5_133916 | All targets in OG5_133916 | |
Brugia malayi | hypothetical protein | Get druggable targets OG5_133916 | All targets in OG5_133916 |
Loa Loa (eye worm) | hypothetical protein | Get druggable targets OG5_133916 | All targets in OG5_133916 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | steroid hormone receptor | vitamin D (1,25- dihydroxyvitamin D3) receptor | 427 aa | 416 aa | 24.5 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Onchocerca volvulus | 0.0094 | 0.0091 | 0.0091 | |
Mycobacterium ulcerans | hypothetical protein | 0.2153 | 0.5831 | 1 |
Trichomonas vaginalis | phosphoglycerate mutase, putative | 0.0062 | 0 | 0.5 |
Onchocerca volvulus | 0.0535 | 0.132 | 0.132 | |
Trichomonas vaginalis | conserved hypothetical protein | 0.0062 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0062 | 0 | 0.5 |
Mycobacterium leprae | Probable phosphoglycerate mutase (phosphoglyceromutase) (phosphoglycerate phosphomutase) | 0.0062 | 0 | 0.5 |
Schistosoma mansoni | lozenge | 0.0067 | 0.0015 | 0.0015 |
Leishmania major | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.3648 | 1 | 1 |
Toxoplasma gondii | phosphoglycerate mutase family protein | 0.0062 | 0 | 0.5 |
Toxoplasma gondii | phosphoglycerate mutase PGMII | 0.0062 | 0 | 0.5 |
Schistosoma mansoni | 6-phosphofructokinase | 0.3648 | 1 | 1 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0566 | 0.1405 | 1 |
Mycobacterium leprae | conserved hypothetical protein | 0.0062 | 0 | 0.5 |
Onchocerca volvulus | 0.3648 | 1 | 1 | |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.3648 | 1 | 1 |
Trichomonas vaginalis | phosphoglycerate mutase, putative | 0.0062 | 0 | 0.5 |
Mycobacterium leprae | probable isochorismate synthase EntC | 0.0062 | 0 | 0.5 |
Toxoplasma gondii | phosphoglycerate mutase | 0.0062 | 0 | 0.5 |
Mycobacterium ulcerans | fructose-2,6-bisphosphatase GpmB | 0.2153 | 0.5831 | 1 |
Loa Loa (eye worm) | runx1 | 0.0067 | 0.0015 | 0.0015 |
Schistosoma mansoni | alpha-glucosidase | 0.014 | 0.0219 | 0.0219 |
Mycobacterium leprae | Possible phosphoglycerate mutase | 0.0062 | 0 | 0.5 |
Echinococcus multilocularis | Protein lozenge | 0.0067 | 0.0015 | 0.0015 |
Chlamydia trachomatis | 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase | 0.0062 | 0 | 0.5 |
Plasmodium vivax | phosphoglucomutase-2, putative | 0.0062 | 0 | 0.5 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.1557 | 0.4169 | 0.4169 |
Trypanosoma brucei | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.1557 | 0.4169 | 0.4169 |
Echinococcus multilocularis | lysosomal alpha glucosidase | 0.0163 | 0.0282 | 0.0282 |
Plasmodium vivax | phosphoglycerate mutase, putative | 0.0062 | 0 | 0.5 |
Trypanosoma brucei | 6-phosphofructo-2-kinase 2 | 0.3586 | 0.9828 | 0.9828 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase 1 | 0.3586 | 0.9828 | 0.9828 |
Treponema pallidum | phosphoglyceromutase | 0.0062 | 0 | 0.5 |
Trypanosoma brucei | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.3648 | 1 | 1 |
Giardia lamblia | Hypothetical protein | 0.2153 | 0.5831 | 0.5 |
Loa Loa (eye worm) | glycosyl hydrolase family 31 protein | 0.0163 | 0.0282 | 0.0282 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.3648 | 1 | 1 |
Mycobacterium ulcerans | short chain dehydrogenase | 0.0566 | 0.1405 | 0.241 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase 1 | 0.3586 | 0.9828 | 0.9828 |
Trichomonas vaginalis | phosphoglycerate mutase, putative | 0.0062 | 0 | 0.5 |
Plasmodium falciparum | phosphoglucomutase-2 | 0.0062 | 0 | 0.5 |
Leishmania major | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.3586 | 0.9828 | 0.9828 |
Toxoplasma gondii | phosphoglycerate mutase family protein | 0.0062 | 0 | 0.5 |
Echinococcus multilocularis | lysosomal alpha glucosidase | 0.0163 | 0.0282 | 0.0282 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.1557 | 0.4169 | 0.4169 |
Mycobacterium leprae | POSSIBLE HYDROLASE MUTT1 | 0.0062 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.3586 | 0.9828 | 0.9828 |
Loa Loa (eye worm) | hypothetical protein | 0.0535 | 0.132 | 0.132 |
Brugia malayi | Glycosyl hydrolases family 31 protein | 0.0163 | 0.0282 | 0.2136 |
Giardia lamblia | Hypothetical protein | 0.2153 | 0.5831 | 0.5 |
Trichomonas vaginalis | phosphoglycerate mutase, putative | 0.0062 | 0 | 0.5 |
Mycobacterium leprae | conserved hypothetical protein | 0.0062 | 0 | 0.5 |
Mycobacterium leprae | PROBABLE PHOSPHOGLYCERATE MUTASE 1 GPM1 (PHOSPHOGLYCEROMUTASE) (PGAM) (BPG-DEPENDENT PGAM) | 0.0062 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.3648 | 1 | 1 |
Schistosoma mansoni | alpha-glucosidase | 0.014 | 0.0219 | 0.0219 |
Loa Loa (eye worm) | hypothetical protein | 0.2091 | 0.566 | 0.566 |
Mycobacterium leprae | conserved hypothetical protein | 0.0062 | 0 | 0.5 |
Mycobacterium leprae | PROBABLE PHOSPHOGLYCERATE MUTASE (PHOSPHOGLYCEROMUTASE) | 0.0062 | 0 | 0.5 |
Toxoplasma gondii | phosphoglycerate mutase family protein | 0.0062 | 0 | 0.5 |
Trichomonas vaginalis | phosphoglycerate mutase, putative | 0.0062 | 0 | 0.5 |
Plasmodium falciparum | phosphoglycerate mutase, putative | 0.0062 | 0 | 0.5 |
Echinococcus multilocularis | 6 phosphofructo 2 kinase:fructose 2 | 0.3648 | 1 | 1 |
Leishmania major | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase-1-like protein | 0.1557 | 0.4169 | 0.4169 |
Brugia malayi | hypothetical protein | 0.0535 | 0.132 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0535 | 0.132 | 0.132 |
Entamoeba histolytica | phosphoglycerate mutase family protein, putative | 0.2153 | 0.5831 | 1 |
Toxoplasma gondii | phosphoglycerate mutase family protein | 0.0062 | 0 | 0.5 |
Echinococcus granulosus | lysosomal alpha glucosidase | 0.0163 | 0.0282 | 0.0282 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (binding) | 0.8913 uM | PUBCHEM_BIOASSAY: qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1484, AID504370, AID504374, AID504375] | ChEMBL. | No reference |
Potency (functional) | = 5.6234 um | PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 15.8489 uM | PUBCHEM_BIOASSAY: Inhibitors of the vitamin D receptor (VDR): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504855] | ChEMBL. | No reference |
Potency (functional) | = 25.1189 um | PUBCHEM_BIOASSAY: qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent). (Class of assay: confirmatory) [Related pubchem assays: 2158 (Confirmation qHTS Assay for Inhibitors of Cruzain), 2249 (Probe Development Summary of Promiscuous Inhibitors (Artifacts) of Cruzain), 2161 (qHTS Assay for Inhibitors of Papain: Counterscreen for Cruzain Assay), 1478 (qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent))] | ChEMBL. | No reference |
Potency (functional) | 100 uM | PUBCHEM_BIOASSAY: Inhibitors of USP1/UAF1: Pilot qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504878] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.